Department of Stem Cell and Regenerative Biotechnology, Konkuk University, Seoul, South Korea.
Korean Minjok Leadership Academy, Sosa-ri, Anheung-myeon, Hoengseong-gun, Gangwon-do, South Korea.
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00530-17. Print 2017 Sep.
In this study, we sought to identify novel antimicrobial peptides (AMPs) in through bioinformatic analyses of publicly available genome information and experimental validation. In our analysis of the python genome, we identified 29 AMP-related candidate sequences. Of these, we selected five cathelicidin-like sequences and subjected them to further analyses. The results showed that these sequences likely have antimicrobial activity. The sequences were named Pb-CATH1 to Pb-CATH5 according to their sequence similarity to previously reported snake cathelicidins. We predicted their molecular structure and then chemically synthesized the mature peptide for three putative cathelicidins and subjected them to biological activity tests. Interestingly, all three peptides showed potent antimicrobial effects against Gram-negative bacteria but very weak activity against Gram-positive bacteria. Remarkably, ΔPb-CATH4 showed potent activity against antibiotic-resistant clinical isolates and also was observed to possess very low hemolytic activity and cytotoxicity. ΔPb-CATH4 also showed considerable serum stability. Electron microscopic analysis indicated that ΔPb-CATH4 exerts its effects via toroidal pore preformation. Structural comparison of the cathelicidins identified in this study to previously reported ones revealed that these Pb-CATHs are representatives of a new group of reptilian cathelicidins lacking the acidic connecting domain. Furthermore, Pb-CATH4 possesses a completely different mature peptide sequence from those of previously described reptilian cathelicidins. These new AMPs may be candidates for the development of alternatives to or complements of antibiotics to control multidrug-resistant pathogens.
在这项研究中,我们通过对公开可用的基因组信息进行生物信息学分析和实验验证,试图在 中鉴定新的抗菌肽(AMPs)。在对 Python 基因组的分析中,我们鉴定出 29 种与 AMP 相关的候选序列。在这些序列中,我们选择了 5 种类似 cathelicidin 的序列,并对它们进行了进一步的 分析。结果表明这些序列可能具有抗菌活性。这些序列根据其与先前报道的蛇 cathelicidins 的序列相似性,被命名为 Pb-CATH1 到 Pb-CATH5。我们预测了它们的分子结构,然后化学合成了三个推定的 cathelicidins 的成熟肽,并对它们进行了生物活性测试。有趣的是,所有三个肽都对革兰氏阴性菌表现出很强的抗菌作用,但对革兰氏阳性菌的活性很弱。值得注意的是,ΔPb-CATH4 对耐药的临床分离株表现出很强的活性,并且观察到其溶血活性和细胞毒性非常低。ΔPb-CATH4 还表现出相当的血清稳定性。电子显微镜分析表明,ΔPb-CATH4 通过环形孔预形成发挥作用。与先前报道的 cathelicidins 的结构比较表明,这些 Pb-CATHs 是缺乏酸性连接结构域的新型 reptilian cathelicidins 的代表。此外,Pb-CATH4 的成熟肽序列与先前描述的 reptilian cathelicidins 完全不同。这些新的 AMPs 可能是开发抗生素替代品或补充物以控制多药耐药病原体的候选物。